Skip to main content
. Author manuscript; available in PMC: 2022 Feb 16.
Published in final edited form as: Curr Cancer Drug Targets. 2016;16(6):489–508. doi: 10.2174/1568009616666151130214646

Fig. (1).

Fig. (1).

Schematic illustration of targeting strategies in drug delivery. Passive targeting is based simply on extravasation of the drug or drug carrier through the leaky vasculature of the tumor. Active targeting is based on the binding of drug or carrier-conjugated ligand to its corresponding receptor on either the tumor endothelial cells (vasculature targeting) or tumor cell surface (tumor targeting).